Back
ACVC Premium Access

hs-troponin should be used in unselected patients with suspected ACS. CONTRA.

Session: Controversies in diagnostic strategies for chest pain patients
Topic: Acute Coronary Syndromes
Speaker: Professor M. Moeckel (Berlin, DE)
Event: Acute Cardiovascular Care 2019

Congress Presentation

About the speaker

Professor Martin Moeckel

Charité - University Medicine Berlin, Berlin (Germany)
13 presentations
2 followers

5 more presentations in this session

hs-troponin should be used in unselected patients with suspected ACS. PRO.

Speaker: Professor B. Lindahl (Uppsala, SE)

Access
Slides
Thumbnail

hs-troponin should be used in unselected patients with suspected ACS. Discussion.

Access
Thumbnail

We need to add a risk score to hs-troponin - PRO.

Speaker: Doctor M. Tubaro (Rome, IT)

Access
Slides
Video
Thumbnail

We need to add a risk score to hs-troponin - CONTRA.

Speaker: Doctor J. Boeddinghaus (Edinburgh, GB)

Access
Slides
Video
Thumbnail

We need to add a risk score to hs-troponin - Discussion.

Access
Thumbnail

Access the full session

Controversies in diagnostic strategies for chest pain patients

Speakers: Professor M. Moeckel, Professor B. Lindahl, Doctor M. Tubaro, Doctor J. Boeddinghaus
Access
Thumbnail

About the event

Image

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb